Millipore Sigma Vibrant Logo

528283 Polo-like Kinase Inhibitor II, BTO-1 - CAS 40647-02-7 - Calbiochem

The Polo-like Kinase Inhibitor II, BTO-1, also referenced under CAS 40647-02-7, controls the biological activity of Polo-like Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: 5-Cyano-7-nitro-2-(benzothiazolo-N-oxide)-carboxamide

View Products on Sigmaaldrich.com
528283
View Pricing & Availability

Overview

Replacement Information

Key Spec Table

CAS #Empirical Formula
40647-02-7C₉H₄N₄O₄S

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
528283-2MG
Retrieving availability...
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Plastic ampoule 2 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      Description
      OverviewA cell-permeable benzothiazolo-N-oxide compound that targets the ATP-binding pocket of polo-like kinase and is shown to inhibit Plk1 kinase activity in cell-free kinase assays (IC50 = 8.0 µM) and suppress the phosphorylation of cellular Plk1 substrate Cdc25C in rat kangaroo kidney-derived PTK cells (75% inhibition at 6.3 µM). BTO-1 treatment of cultured cells results in mitosis defects consistent with loss-of-Plk1 phenotypes seen in Plk1 RNAi-treated U20S cells, including the appearance of monopolar spindles and the reduction of γ-tubulin at the centrosomes. Plk1 inhibition by BTO-1 in HeLa cells results in a blockage of Rho and Rho-GEF recruitment, which is essential for the assembly of a functional contractile ring.
      Catalogue Number528283
      Brand Family Calbiochem®
      Synonyms5-Cyano-7-nitro-2-(benzothiazolo-N-oxide)-carboxamide
      References
      ReferencesBrennan, I.M., et al. 2007. PloS ONE 2, e409.
      Peters, U., et al. 2006. Nat. Chem. Biol. 2, 618.
      McInnes, C., et al. 2006. Nat. Chem. Biol. 2, 608.
      Product Information
      CAS number40647-02-7
      FormBeige to brown solid
      Hill FormulaC₉H₄N₄O₄S
      Chemical formulaC₉H₄N₄O₄S
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥97% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 20/21/22-36/37/38

      Harmful by inhalation, in contact with skin and if swallowed.
      Irritating to eyes, respiratory system and skin.
      S PhraseS: 26-36/37

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing and gloves.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      528283-2MG 04055977196580

      Documentation

      Polo-like Kinase Inhibitor II, BTO-1 - CAS 40647-02-7 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      Polo-like Kinase Inhibitor II, BTO-1 - CAS 40647-02-7 - Calbiochem Certificates of Analysis

      TitleLot Number
      528283

      References

      Reference overview
      Brennan, I.M., et al. 2007. PloS ONE 2, e409.
      Peters, U., et al. 2006. Nat. Chem. Biol. 2, 618.
      McInnes, C., et al. 2006. Nat. Chem. Biol. 2, 608.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision30-August-2016 JSW
      Synonyms5-Cyano-7-nitro-2-(benzothiazolo-N-oxide)-carboxamide
      DescriptionA cell-permeable benzothiazolo-N-oxide compound that targets the ATP-binding pocket of polo-like kinase and is shown to inhibit Plk1 kinase activity in cell-free kinase assays (IC50 = 8.0 µM) and suppress the phosphorylation of cellular Plk1 substrate Cdc25C in rat kangaroo kidney-derived PTK cells (75% inhibition at 6.3 µM). BTO-1 treatment of cultured cells results in mitosis defects consistent with loss-of-Plk1 phenotypes seen in Plk1 RNAi-treated U20S cells, including the appearance of monopolar spindles and the reduction of γ-tubulin at the centrosomes. Plk1 inhibition by BTO-1 in HeLa cells results in a blockage of Rho and Rho-GEF recruitment, which is essential for the assembly of a functional contractile ring.
      FormBeige to brown solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number40647-02-7
      Chemical formulaC₉H₄N₄O₄S
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityDMSO (1 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Harmful
      ReferencesBrennan, I.M., et al. 2007. PloS ONE 2, e409.
      Peters, U., et al. 2006. Nat. Chem. Biol. 2, 618.
      McInnes, C., et al. 2006. Nat. Chem. Biol. 2, 608.